Mode
Text Size
Log in / Sign up
N/A N=68 Prevention

Residential MapTrek- Increasing Physical Activity Among Older Adults in a Residential-Living

Sedentary Behavior

Enrolled (actual)
68
Serious AEs
0.0%
Results posted
Aug 2022
Primary outcome: Primary: Physical Activity — 6681 Steps/day — p=<0.01

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
MapTrek (Behavioral)
Age
Adult, Older Adult · 25+ yrs
Sex
All
Sponsor
University of Iowa
Primary completion
Sep 2019

Outcome Measures

OutcomeResultp-value
PRIMARY
Physical Activity
6681 <0.01 sig
SECONDARY
Self-efficacy
67.4
SECONDARY
Social Support
2.2
SECONDARY
Outcome Expectations
4.4
SECONDARY
Social Isolation
17.6

Summary

Older adults are a growing population, with projections to reach 83.7 million by 2050. Furthermore, older adults are the most sedentary and least physically active adult population. It is estimated that nearly 90% of older adults 65 years of age or older do not meet the recommended levels of physical activity. Evidence suggests great health benefits can be achieved for older adults who are the most sedentary, and that replacing sitting with even light intensity walking can be beneficial. The overarching goal of the project is to develop an inexpensive and scalable tool to increase volume of physical activity in our target population, older adults living in a residential facility. MapTrek is a web-based application that allows participants to take a virtual walk in interesting locations around the world while tracking their progress against the progress of other older adults living in a retirement community. Steps are counted using a commercially available accelerometer (e.g., Fitbit), and participants see their progress overlaid on Google Maps.

Eligibility Criteria

Inclusion Criteria

  • To be eligible, participants much be between 25 and 100 years of age, physically able to walk without limitations

Exclusion Criteria

  • Patients with cognitive or physical limitations that prohibit walking and visual or cognitive impairments causing inability to read.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04041869). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search